Ocrevus
Ocrevus is an originator product from Roche Pharma (Schweiz) AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 5'054.50 to CHF 5'054.50 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Roche Pharma (Schweiz) AG
- ATC code
- L04AG08
- IT group
- 01.99 Varia
- Active substances
- Ocrelizumabum
- Preparation type
- Originator product
- On the SL since
- 01/03/2018
- Last price change
- 01/10/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inf Konz 300 mg/10 ml | Durchstf 1 Stk | CHF 4'632.46 | CHF 5'054.50 | 01/10/2025 | A | 7680661850010 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Für die Behandlung von erwachsenen Patienten mit primär progredienter Multipler Sklerose (PPMS) zur Verlangsamung der Krankheitsprogression und zur Reduzierung der Verschlechterung der Gehgeschwindigkeit.
Die Roche Pharma (Schweiz) AG erstattet dem Krankenversicherer, bei dem die versicherte Person zum Zeitpunkt des Bezugs versichert war auf dessen erste Aufforderung hin für jede bezogene Durchstfl OCREVUS Inf Konz 300 mg/10 ml, einen Anteil von Fr. 731.07 pro Durchstfl OCREVUS zurück. Die Mehrwertsteuer kann nicht zusätzlich zu diesem Anteil des Fabrikabgabepreises zurückgefordert werden. Die Aufforderung zur Rückerstattung soll ab dem Zeitpunkt der Verabreichung erfolgen.
More preparations in this group
FAQ
Is Ocrevus covered by Swiss health insurance?
Yes, but only under conditions. Ocrevus is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Ocrevus cost in Switzerland?
The public price is the maximum price set by the FOPH and for Ocrevus ranges from CHF 5'054.50 to CHF 5'054.50 per pack. The ex-factory price ranges from CHF 4'632.46 to CHF 4'632.46. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages